NewEdge Advisors’s BioVie BIVI Stock Holding History

NewEdge Advisors’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19	Hold	10	–	–	﹤0.01%	4165
2026 Q1	$14	Hold	10	–	–	﹤0.01%	4109
2025 Q4	$12	Hold	10	–	–	﹤0.01%	4192
2025 Q3	$19	Hold	10	–	–	﹤0.01%	4071
2025 Q2	$93	Sell	10 -5,400	-100%	-$53.3K	﹤0.01%	3910
2025 Q1	$53K	Buy	5,410 +4,000	+284%	+$63.9K	﹤0.01%	2537
2024 Q4	$28.2K	Buy	1,410 +1,400	+14,000%	+$33.8K	﹤0.01%	2703
2024 Q3	$120	Hold	10	–	–	﹤0.01%	3713
2024 Q2	$401	Hold	10	–	–	﹤0.01%	3591
2024 Q1	$529	Hold	10	–	–	﹤0.01%	3579
2023 Q4	$1.26K	Hold	10	–	–	﹤0.01%	3425
2023 Q3	$3.24K	Buy	10 +8	+400%	+$3.13K	﹤0.01%	2933
2023 Q2	$862	Hold	2	–	–	﹤0.01%	3267
2023 Q1	$1.62K	Buy	2 +1	+100%	+$663	﹤0.01%	3081
2022 Q4	$1	Buy	+1	New	+$541	﹤0.01%	3984

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

NewEdge Advisors's BIVI Position: Q2 2026 in Review

NewEdge Advisors held its BioVie (BIVI) position steady in Q2 2026 at 10 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #4165.

NewEdge Advisors first reported a position in BIVI in Q4 2022 and has held it in 15 quarters since. The position peaked at $53K in Q1 2025. 35 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

NewEdge Advisors held 10 shares of BioVie worth $19 as of Q2 2026.
NewEdge Advisors left its BioVie share count unchanged in Q2 2026.
BioVie made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4165 holding.
NewEdge Advisors first reported a position in BioVie in Q4 2022 and has held it in 15 quarters since.
NewEdge Advisors's BioVie position peaked at $53K in Q1 2025.
35 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.